the outcome of low dose and high-dose corticosteroid in the treatment of granulomatous mastitis

Comparison of the outcome of low dose and high-dose corticosteroid in the treatment of granulomatous mastitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120605009948N8

Enrollment

Registered

2019-10-13

Start date

2017-04-19

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

granulomatous mastitis. Inflammatory disorders of breast

Interventions

Intervention 1: Intervention group: Prednisolone will be administered 5 mg daily for two months. Intervention 2: Intervention group: Prednisolone will be administered 50 mg per day for 3 days, 25 mg f

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women with Idiopathic granulomatous mastitis age > 18 years

Exclusion criteria

Exclusion criteria: Pregnant women women with non-idiopathic granulomatous mastitis women with infectious diseases and allergies contraindications to use corticosteroids

Design outcomes

Primary

Measure	Time frame
Response to treatment. Timepoint: Before and two months after treatment. Method of measurement: physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahid Montazer Bavil

Tabriz University of Medical Sciences

montazerma@tbzmed.ac.ir+98 41 3335 7852

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026